Core Insights - The 34th European Academy of Dermatology and Venereology (EADV 2025) concluded successfully in Paris, where the Chinese beauty brand, Shangmei Co., made a significant debut by releasing the "2025 KANSU Peptide Research and Efficacy Skincare Application Yearbook" [1] - This publication, which encapsulates 22 years of research on peptides by KANSU, was also showcased at the 2025 China Fragrance and Cosmetic Industry Annual Conference and Expo (CAME), highlighting China's innovative contributions to anti-aging solutions [1] Group 1 - The "KANSU Peptide Yearbook" is edited by renowned dermatology experts, showcasing the brand's deep commitment to peptide research and establishing its credibility in the field [3] - The yearbook serves as a practical guide for consumers and a testament to the brand's long-term commitment to scientific development in the industry [6] - It outlines a comprehensive framework that combines global perspectives with local insights, detailing over 50 years of peptide technology evolution [6] Group 2 - The yearbook presents significant market transformation results, with the "Red Waist 2.0" series showing a 38.57% reduction in cheek wrinkle length and a 33.83% increase in skin hydration [7] - The KANSU X Peptide Super Frequency Cream demonstrated a 27.59% increase in collagen and a 30.57% improvement in elastin after 28 days of testing, setting new industry benchmarks [7] - These quantifiable results address the industry's challenge of measuring anti-aging effects, providing consumers with clear efficacy references [7] Group 3 - The yearbook emphasizes the importance of long-term research investment in building core competitiveness in the anti-aging sector, reflecting on the industry's short-termism [10] - It documents KANSU's journey from initiating peptide research in 2003 to achieving significant milestones in innovation and application [11] - The yearbook's authority stems from KANSU's unique research accumulation and international recognition, showcasing a robust peptide research system [11] Group 4 - Karl Lintner, a pioneer in peptide technology, praised KANSU's application of cyclic peptides, affirming its contributions to foundational research and product development [13] - The dual launch at EADV and CAME signifies KANSU's strategic positioning to engage globally while remaining rooted in China [13] - The yearbook sets future goals for KANSU to leverage AI and computational biology in advancing peptide research, marking a transition from "Made in China" to "Intelligent Manufacturing in China" [13]

Core Viewpoint - Natural堂 has officially submitted its IPO application to list on the Hong Kong stock market, aiming to capitalize on the favorable market conditions and competitive pressures from other domestic beauty brands [1][2]. Group 1: IPO and Market Position - Natural堂 is the third-largest domestic cosmetics group in China and the second-largest domestic cosmetics brand based on retail sales projected for 2024 [2]. - The company has seen a significant increase in its online sales channel, with the proportion rising from 59.7% in 2022 to 68.8% in the first half of 2025 [5]. - The CEO, Zheng Chunying, and her family control approximately 87.82% of the voting rights, which may limit the influence of minority shareholders [3]. Group 2: Financial Performance - Natural堂's revenue for 2022, 2023, and 2024 is projected to be 42.92 billion, 44.42 billion, and 46.01 billion respectively, with net profits of 1.39 billion, 3.02 billion, and 1.90 billion [4]. - The company's gross profit margin has improved from 66.5% in 2022 to 70.1% in the first half of 2025, but its net profit margin remains relatively low at 7.8% [6]. - Compared to competitors like Perleya and Shuangmei, which have seen significant revenue and profit growth, Natural堂's growth has been modest, with revenue growth rates of only 3.48% and 3.58% in 2023 and 2024 respectively [4][6]. Group 3: Brand Strategy and Challenges - Natural堂 operates five main cosmetic brands, with the flagship brand contributing over 94% of total revenue, indicating a lack of diversification [5][6]. - The company has not successfully developed new growth brands, unlike competitors who have launched successful new lines, which poses a challenge for future growth [6]. - The conservative management style of the founder may have contributed to the slower growth and lower profitability compared to more aggressive competitors [4][6].

Core Insights - The Chinese beauty industry is experiencing a significant transformation, with many brands exiting the market while others are rapidly launching new sub-brands to adapt to changing consumer demands and market conditions [1][8][24]. Group 1: Industry Trends - The beauty industry is facing a "winter" period, leading to the exit of several brands such as Qiaodi Shanghui and Jing Sheng Zhi Yuan [1]. - Despite the challenges, there is a surge in new brand launches, indicating a robust response from leading companies [1][8]. - Major players like Shangmei Co., Beitaini, and Polaroid are actively developing multiple sub-brands to enhance their market presence [8][24]. Group 2: Company Strategies - Shangmei Co. has launched three new brands this year, including NAN beauty, a high-end anti-aging brand Tazu, and a baby care brand [10][11]. - Beitaini is set to introduce a new acne treatment brand, Ansta, which has been in development for three years [15][16]. - Polaroid is considering overseas acquisitions to fill gaps in its product offerings, targeting markets such as baby care and men's grooming [17][24]. Group 3: Market Positioning - The multi-brand strategy allows companies to cater to diverse consumer needs across different demographics, enhancing their competitive edge [24][29]. - Companies are focusing on leveraging their main brand strengths to create differentiated sub-brands that address specific market segments [27][30]. - The trend of building a multi-brand matrix is becoming standard among leading beauty companies in China, moving away from a single-brand dominance [28][39]. Group 4: Growth Strategies - Companies are employing both internal brand incubation and external acquisitions as primary methods for expanding their brand portfolios [29][33]. - Internal incubation allows companies to innovate and meet emerging consumer demands effectively, while acquisitions provide immediate access to established brands and markets [32][38]. - The balance between these strategies is crucial for sustained growth and market relevance in a competitive landscape [39].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02145 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 206,319,319 | RMB | | 1 | RMB | | 206,319,319 | | 增加 / 減少 (-) | | | 35,223 | | | | RMB | | 35,223 | | 本月底結存 | | | 206,354,542 | RMB | | 1 | RMB | | 206,354,542 | | 2. 股份分類 | 普通股 | 股份類別 | 其他類別 (請註明) | | ...

Group 1 - The Hong Kong stock market saw a decline in new consumption concept stocks, with notable drops in companies such as Pop Mart, Miniso, and Gu Ming [1] - Pop Mart experienced a decline of 4.95%, with a latest price of 253.600 and a total market capitalization of 340.57 billion, while year-to-date growth stands at 185.71% [2] - Miniso's stock fell by 3.01%, with a latest price of 43.200 and a market cap of 52.777 billion, reflecting a year-to-date decline of 5.78% [2] Group 2 - Gu Ming's stock decreased by 2.15%, with a latest price of 21.820 and a market cap of 51.892 billion, showing a year-to-date increase of 119.52% [2] - Lao Pu Gold saw a drop of 1.62%, with a latest price of 700.500 and a market cap of 120.96 billion, while year-to-date growth is at 198.95% [2] - Bluco's stock fell by 1.65%, with a latest price of 89.200 and a market cap of 22.193 billion, reflecting a year-to-date increase of 47.80% [2]

Core Insights - The beauty industry in China is experiencing significant changes, with a focus on high-end fragrance brands, domestic beauty brands' performance, and the integration of science and global strategies in the market [2][3][4][5][6][7]. Industry Environment - Douyin e-commerce has revitalized the perception of "Chinese good ingredients," showcasing natural components from local brands and enhancing consumer trust through expert endorsements and interactive marketing [3]. High-End Fragrance Market - The fragrance category is witnessing growth despite overall market pressures, with projections indicating the Chinese perfume market will reach 24.9 billion yuan by 2025 and exceed 33.9 billion yuan by 2028, reflecting a compound annual growth rate of 8% [4]. Domestic Beauty Brands Performance - In the first half of 2025, the domestic beauty market grew by 3.1%, with leading brands like Proya achieving 5.36 billion yuan in revenue, while others like Huaxi Biological faced challenges [5]. Globalization and Scientific Innovation - The second half of the domestic beauty market is expected to focus on scientific advancements, segmentation of consumer scenarios, and globalization strategies [7]. Medical Beauty and Cosmetic Integration - The medical beauty sector is projected to grow at a compound annual growth rate of 10%-15% from 2024 to 2027, with brands increasingly merging beauty and medical aesthetics to meet consumer demands for comprehensive care [10]. E-commerce and Brand Strategies - E-commerce operators in the beauty sector are facing challenges, with only one company, Ruoyu Chen, showing significant growth amidst a broader industry slowdown [14]. New Product Launches and Brand Collaborations - Major brands like L'Oréal are expanding into the fragrance market with new high-end products, while emerging brands like Huaxizi are innovating in skincare with a focus on traditional Chinese medicine [16][17]. Market Trends and Consumer Behavior - The beauty market is seeing a shift towards affordable and effective products, with brands needing to adapt to changing consumer preferences and the competitive landscape [12][25].

Group 1 - The company, Shangmei Co., Ltd. (stock code: 02145), announced the adoption of a restricted stock unit incentive plan on December 14, 2023 [1] - Under this plan, the company will issue and allocate 35,200 H-shares by September 30, 2025 [1]

Core Viewpoint - The company, Shangmei Co., Ltd. (02145.HK), announced the grant of a total of 51,130 restricted stock units to five grantees under its incentive plan, representing 0.01% of the total shares issued as of the announcement date [1] Summary by Category - **Company Announcement** - Shangmei Co., Ltd. will grant 51,130 restricted stock units to five individuals [1] - The total number of shares granted represents 0.01% of the company's total issued shares as of the announcement date [1]

Core Points - The company announced the adoption of a restricted stock unit incentive plan on December 14, 2023 [1] - The company plans to issue and allocate 35,200 H-shares by September 30, 2025 [1]

Core Viewpoint - The company, Shangmei Co., Ltd. (stock code: 02145), announced the grant of a total of 51,100 restricted stock units to five grantees under its restricted stock unit incentive plan, representing 0.01% of the total issued shares as of the announcement date [1] Summary by Category - **Company Announcement** - Shangmei Co., Ltd. will grant 51,100 restricted stock units to five individuals [1] - The granted units correspond to 51,100 shares, which is 0.01% of the total issued shares as of the announcement date [1]